SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001013594-16-000722
Filing Date
2016-02-16
Accepted
2016-02-16 10:54:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 16, 2016 dipexium13ga-021616.htm SC 13G/A 62121
  Complete submission text file 0001013594-16-000722.txt   63856
Mailing Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006
Business Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006 212-269-2834
Dipexium Pharmaceuticals, Inc. (Subject) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88072 | Film No.: 161424550
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 MADISON AVENUE 26TH FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 26TH FLOOR NEW YORK NY 10022 212-554-2500
Tourbillon Capital Partners, L.P. (Filed by) CIK: 0001592476 (see all company filings)

IRS No.: 460724833 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A